Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company’s patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Intellipharmaceutics has developed several drug delivery systems based on this technology platforms, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505 (b)(2) drug delivery product candidates in its development pipeline in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract, diabetes and pain.
30 Worcester Road
Toronto, ON M9W 5X2
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical and Medicine Industry (3741)